XML 22 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues:        
Premiums $ 18,983 $ 16,927 $ 37,943 $ 34,567
Net investment income 289 184 586 346
Total revenues 72,616 65,341 141,713 132,096
Operating costs:        
Cost of products sold $ 43,520 $ 40,242 $ 84,414 $ 80,589
Cost, Product and Service [Extensible List] Products Products Products Products
Benefit costs $ 15,901 $ 11,751 $ 31,605 $ 26,138
Operating expenses 8,869 8,668 17,791 17,231
Total operating costs 68,290 60,661 133,810 123,958
Operating income 4,326 4,680 7,903 8,138
Interest expense 636 765 1,293 1,498
Other income (45) (45) (95) (99)
Income before income tax provision 3,735 3,960 6,705 6,739
Income tax provision 944 974 1,690 1,741
Net income 2,791 2,986 5,015 4,998
Net income attributable to noncontrolling interests (8) (11) (9) (16)
Net income attributable to CVS Health $ 2,783 $ 2,975 $ 5,006 $ 4,982
Net income per share attributable to CVS Health:        
Net income per share attributable to CVS Health, basic (in dollars per share) $ 2.11 $ 2.27 $ 3.80 $ 3.81
Net income per share attributable to CVS Health, diluted (in dollars per share) $ 2.10 $ 2.26 $ 3.78 $ 3.79
Weighted average shares outstanding:        
Weighted average basic shares outstanding (in shares) 1,319 1,309 1,316 1,307
Weighted average diluted shares outstanding (in shares) 1,327 1,314 1,325 1,313
Dividends declared per share (in dollars per share) $ 0.50 $ 0.50 $ 1.00 $ 1.00
Products        
Revenues:        
Revenues $ 50,525 $ 46,355 $ 97,912 $ 93,358
Services        
Revenues:        
Revenues $ 2,819 $ 1,875 $ 5,272 $ 3,825